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1. Introduction 
Numerous physiological and biochemical processes 
of the animal cell are mediated through the availability 
of Ca ions in the PM concentration range. Ca*+ regula- 
tion is usually triggered by its action on specific Ca*+ 
binding proteins. Troponin C (TNC) of skeletal muscle 
is a typical example of this kind of protein. This 
highly acidic component of the tropomyosin-troponin 
system binds Ca*+ with high affinity and confers Ca*+ 
sensitivity to actomyosin [l] . Most recently it has 
been established that the Ca*‘-dependent protein 
activator of cyclic nucleotide metabolism (PA) [2,3] 
in brain and heart tissues is also a TNC-like protein 
[4-71. TNC and PA although clearly distinguishable 
from each other have quite a few common properties 
and probably evolved from a common ancestor 
[4-71. 
In blood platelets, the availability of Ca*’ is a 
prerequisite for several steps of haemostatic activation 
[8 J . The contractile activity of platelet-rich plasma 
clots [9] as well as ‘natural’ platelet actomyosin also 
possesses Ca*+ sensitivity [IO] . Although the existence 
of platelet TNC was assumed several years ago [ 111 
so far no TNC-like protein has been isolated from 
these cells. The aim of the present study was to 
identify and isolate a TNC-like protein from bovine 
platelets and to establish if it is equivalent to brain 
PA or to muscle TNC. 
2. Materials and methods 
Platelets were obtained from titrated bovine 
blood by differential centrifugation. The isolation 
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of rabbit skeletal muscle TNC and troponin I (TNI) 
was carried out according to Drabikowski et al. [12] . 
Highly purified PA and activator deficient cyclic 
nucleotide phosphodiesterase were prepared from 
bovine brain [5] Cyclic AMP phosphodiesterase 
activity was determined in the presence of 0.1 mM 
Ca*+ by a two-stage assay [5] measuring the phos- 
phate liberated [ 131 in the second stage. Alkaline 
urea (AU) [ 14 ] and sodium dodecylsulfate (SDS) 
[ 1.51 polyacrylamide gel electrophoresis (PAGE) were 
performed in 8.0% and 12.5% gels, respectively. 
Preparative AU PAGE was carried out on a Poly-prep 
200 (Buchler) equipment. The following reference 
proteins were used for molecular weight determination 
by SDS PAGE: TNI, TNC, myoglobin and cytochrom 
c (Boehringer). Absorbance spectrum was recorded 
on a Unicam SP 8000 spectrophotometer. Fluores- 
cence was measured using a Perkin-Elmer MPF-2L 
spectrofluorometer. The apparent Ca*+ binding 
constant was calculated by transition midpoint 
analysis of the fluorescence change upon addition of 
Ca*+ [ 161 Protein concentration was estimated by 
Lowry’s procedure or UV absorbance measurement. 
3. Results and discussion 
For the detection of TNC-like protein in platelet 
homogenate we took the advantage of AU PAGE. In 
this system if Ca*+ is removed the highly negatively 
charged TNC moves far ahead of the bulk of the 
other proteins. If both Cap and a TNC-binding 
protein, e.g., TN1 are present a complex with slower 
mobility is formed and the band corresponding to 
TNC disappears [ 141. This kind of approach has been 
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successfully applied to the detection of TNC-like 
protein in brain tissue [ 171 . In whole platelet homo- 
genate if EGTA was added two fast moving bands 
could be detected by AU PAGE (fig.1). In the 
presence of Ca” one of them, like TNC in muscle 
or brain homogenate, disappeared while the other 
remained, even if muscle TN1 was included (not 
shown). The latter band probably represents the 
light chains of platelet myosin which in alkaline urea 
gel move together and with higher mobility than any 
of the light chains of skeletal muscle myosin [ 181 , 
even slightly faster than TNC [ 191 . 
The protein corresponding to the band with TNC- 
like behaviour was isolated, partially characterized 
and compared to skeletal muscle TNC and to the PA 
of brain. To get rid of myosin components and some 
other proteins platelets were treated with acetone then 
Fig.1. Alkaline urea polyacrylamide gel electrophoresis of 
platelet homogenate (A, B) and 1 M KC1 extract of platelet 
acetone powder (C, D). 5 mM EGTA (A, C) or 1 mM CaC1, 
(B, D) were added to the samples and 400 c(g (A, B) or 200 pg 
(C, D) protein was applied onto the gels. The homogenate 
was prepared as described by Fine et al. [ 171 for brain tissue. 
extracted by 1 M KCl. The extract was exhaustively 
dialyzed against 0.5 mM DTT solution (pH 7.0), and 
the precipitate which formed was removed by centri- 
fugation. In the supernatant, although still a crude 
mixture of proteins, only one fast moving band - the 
one with the ability of forming a complex in the 
presence of Ca2+ - could be detected (fig.1). Further 
purification by preparative AU PAGE resulted in a 
highly purified protein. A single band was seen when 
it was subjected to analytical AU and SDS PAGE 
(flg.2). 
This protein shared the common properties of 
TNC-like proteins. Like TNC [16] and PA [7] it 
exhibited a fluorescence emission spectrum (maximum 
at 306 nm) characteristic of tyrosine peptides, and the 
removal of Ca2+ resulted in a decrease of fluorescence 
intensity. It possessed an absorbance spectrum 
common for polypeptides with a high phenylalanine : 
tyrosine ratio and as other TNC-like proteins [4,5] 
showed considerable vibrational structure in the region 
of 250 to 280 nm (peaks were seen at 253,258,264, 
268 and 275 nm, E, mg/ml, 275 r,rrr = 0.18). The electro- 
phoretic behaviour of the platelet protein in alkaline 
urea gel again resembled TNC [ 14,201 and brain PA 
[6,7]. Its mobility corresponded to that of other 
TNC-like proteins, was increased by Ca2’ and if TN1 
was also included complex formation occurred (fig.2). 
These findings clearly prove that a TNC-like protein 
does exist in platelets, but still leave open the question 
whether muscle TNC or PA is the equivalent of it. 
Drabikowski et al. [7] have shown that in AU 
PAGE the complex of brain PA and TN1 migrated 
significantly slower than the TNC-TN1 complex. The 
complex of platelet protein and TN1 moved with the 
same mobility as PA-TN1 (fig.2a). The molecular 
weight of platelet protein was found to be 16 500 by 
SDS PAGE. It co-migrated with brain PA but not with 
TNC (18 000) (tig.2b). The binding constant of 
platelet protein for Ca2+ was estimated to be 4.2 X lo6 
M-’ by fluorescence titration. The respective values 
based on the same fluorescence method for brain PA 
and TNC are 1 X 10’ M-’ and 5 X 10’ M-r [7]. 
Finally, in the presence of Ca” the TNC-like protein 
of platelets activated activator deficient brain phos- 
phodiesterase in a manner identical to brain PA while 
TNC in the same concentration was without effect 
(fig.3). To sum up, in certain characteristics platelet 
TNC-like protein clearly differs from TNC but is 
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Fig. 2a 
indistinguishable from brain PA, i.e., the protein we 
isolated has to be considered as the platelet protein 
activator of cyclic nucleotide metabolism. 
In the presence of Ca*+ PA stimulates the activity 
of cyclic nucleotide phosphodiesterase [2 1,221 and 
solubilized adenyl cyclase [23,24] , It probably plays 
a key regulatory role in the cyclic nucleotide meta- 
bolism. Changes of cyclic nucleotide metabolism and 
increase in intracellular Ca*’ concentration are deeply 
involved in platelet functions such as shape change, 
aggregation and release reaction [8,2.5] and PA may 
provide a link of high significance between the two 
mechanisms. Smoake et al. [26] have demonstrated a 
Fig.Zb 
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Fig.2. Electrophoretic behaviour of the TNC-like protein 
from platelets in alkaline urea (a) and SDS (b) polyacrylamide 
gel. (a): 1 mM CaCl, or 5 mM EGTA were included into the 
samples. 3 pg brain PA, 1 ng platelet protein, 3 fig TNC and 
10 pg TN1 were applied onto the gels. (A) Brain PA + Ca’+; 
(B) brain PA + EGTA; (C) platelet protein + Ca’+; (D) platelet 
protein + EGTA; (E) TNC + Ca*+; (F) TNC + EGTA; (G) brain 
PA + TN1 + Ca’+; (H) platelet protein + TN1 + Ca’+; (I) TNC + 
TN1 + Ca2+; (J) TN1 + Ca*+. (b): (A) platelet protein 5 pg; 
(B) platelet protein 5 pg + brain PA 5 pg; (C) TNC 3 pg; 
(D) TNC 2 pg + platelet protein 4 pg. 
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Fig.3. Effect of TNC-like protein from platelets, brain PA and 
TNC on the activity of activator deficient brain phosphodi- 
esterase. Platelet protein (0 -0); brain PA (o-o); 
TNC (X- - - X). Activity was measured on 0.07 units [6] of 
the enzyme. The amount of different TNC-like proteins in 
the assay mixture is indicated on the abscissa. 
hitherto unidentified factor in platelet homogenate 
that in the presence of Ca*’ activated cyclic nucleo- 
tide phosphodiesterase. The TNC-like protein isolated 
and characterized in this study is in all probability 
the entity responsible for the effect observed by those 
authors. 
In an earlier paper Cohen et al have provided some 
evidence for an actin-linked Ca*+ regulatory mecha- 
nism in platelet actomyosin [ 1 l] . More recently, 
however, a myosin-connected Ca*+ regulation was 
verified in this system [ 191. Here, we showed that 
beside PA no other TNC-like protein exists in platelets. 
It is interesting to note that in a reconstituted skeletal 
muscle actomyosin system brain [6] as well as testis 
[27] PA exerted TNC-like activity conferring Ca*+ 
sensitivity to it. A similar activity of platelet PA in 
in vivo conditions can be also surmised although 
during a conventional actomyosin purification proce- 
dure it does not copurify with the actomyosin complex 
u91. 
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